Which of the following anticoagulant should not be given during pregnancy?

NORCET 6 mains-2024

Pharmacology

Easy

Appeared in: NORCET 6 mains-2024

Explanation

Warfarin is a known teratogen because its small molecular size allows it to cross the placental barrier, posing significant risks to the developing fetus.
Exposure during the first trimester can lead to Fetal Warfarin Syndrome, characterized by nasal hypoplasia (underdeveloped nose) and bone abnormalities (chondrodysplasia punctata).
Throughout pregnancy, Warfarin use increases the risk of fetal hemorrhage, spontaneous abortion, stillbirth, and central nervous system defects.

Option B: Heparin is a large molecule that does not cross the placenta, making it a safe and often preferred anticoagulant during pregnancy.
Option C: Similar to unfractionated heparin, Low Molecular Weight Heparin (LMWH) does not cross the placenta and is considered safe and effective for use in pregnant women.
Option D: This option is incorrect because Heparin and LMWH are considered safe for use during pregnancy, while Warfarin is not.

Visual 1: Diagram: A visual comparing the molecular structures of Warfarin and Heparin, illustrating how Warfarin's small size allows it to cross the placenta while Heparin's large size prevents it.
Visual 2: Infographic: Key features of Fetal Warfarin Syndrome, showing a baby with nasal hypoplasia and explaining the associated bone defects.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology: Anticoagulant contraindications in pregnancy as background academic context rather than a clinical decision trigger.
Nurses must provide pre-conception counseling to women on chronic warfarin therapy (e.g., for mechanical heart valves), advising them to switch to heparin or LMWH before conception or immediately upon discovering they are pregnant.
Patient education is critical. The nurse must clearly explain the risks of warfarin to the fetus and the importance of adhering to the safer prescribed alternative (Heparin/LMWH) to ensure both maternal and fetal well-being.
What if? If a pregnant patient with a mechanical heart valve has a very high risk of thrombosis, a specialist may manage a complex regimen involving LMWH in the first trimester, a switch to low-dose warfarin in the second and third trimesters (if the dose is less than 5 mg/day), and then back to LMWH before delivery. This requires intensive monitoring and a multidisciplinary team approach.

How to Approach the Question

First, identify the core of the question: which anticoagulant is unsafe ('should not be given') in pregnancy?
Recall the key pharmacological properties of common anticoagulants regarding pregnancy. The main differentiating factor is the ability to cross the placenta.
Remember that Warfarin is a small molecule that crosses the placenta and is a known teratogen.
Recall that Heparin and LMWH are large molecules that do not cross the placenta, making them the drugs of choice for anticoagulation during pregnancy.
Based on this knowledge, identify Warfarin as the contraindicated drug and eliminate the other options.

Concept Tested & Keywords

Concept Tested: Pharmacology: Anticoagulant contraindications in pregnancy
Stem keywords: anticoagulant, pregnancy
Lead-in keywords: not be given
Negative lead-in flag: The question asks which drug should NOT be given, requiring identification of the contraindicated medication.

Qg-o3csFvFtIRk_0dUXUJx